1-3 of 3
Michael Peres
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Immune Recovery Refines the Prognostic Impact of Minimal Residual Disease on Overall and Progression Free Survivals after Frontline Fludarabine, Cyclophosphamide and Rituximab (FCR) in CLL Patients

Martin Gauthier, Florence Durrieu, Michael Peres, MD, Elodie Martin, MSc, Thomas Filleron, PhD, Christian Recher, MD PhD, Anne Quillet Mary, PhD, Loic Ysebaert, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1731.
https://doi.org/10.1182/blood.V130.Suppl_1.1731.1731
Published: 2017
Journal Articles

First Interim Analysis of the French National Observatory of Paroxysmal Nocturnal Hemoglobinuria Clones

Magali Le Garff-Tavernier, Bernard Drenou, MD, Agathe Pruvot Debliquis, Remi Letestu, Bernard Chatelain, PhD BPharm, Thomas Boyer, Jean-Philippe Vial, MD, Michael Peres, MD, Véronique Harrivel, MD, Gérard Socié, MDPhD, Regis Peffault De Latour, MD PhD, Orianne Wagner Ballon
Journal: Blood
Blood (2017) 130 (Supplement 1): 4960.
https://doi.org/10.1182/blood.V130.Suppl_1.4960.4960
Published: 2017
Journal Articles

Immunophenotypic-Defined Stage of Leukemia Differentiation Arrest Identifies Oncogenic and Metabolic Signatures in AML

Francois Vergez, DVM, PhD, Sarah Bertoli, MD PhD, Marina Bousquet, PhD, Marie-Laure Nicolau-Travers, Michael Peres, PharmD, Estelle Saland, Françoise Huguet, MD, Isabelle Luquet, MD, Veronique Mansat-de Mas, PharmD, PhD, Cecile Demur, MD, Eric Delabesse, MD PhD, Gwenn Danet-Desnoyers, PhD, Jean-Emmanuel Sarry, PhD, Christian Récher, MDPhD
Journal: Blood
Blood (2015) 126 (23): 90.
https://doi.org/10.1182/blood.V126.23.90.90
Published: 2015